Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.44 |
| ▸ | TACR2 | P21452 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5326029 | 1.00 | LGALS3 (0.44) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL19818851 | 0.99 | LGALS3 (0.43) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL28529577 | 0.92 | LGALS3 (0.51) | LGALS3SLC6A2SSTR4SSTR5LGALS9 | |
| SCHEMBL15422703 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL3489622 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL15652660 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL13498636 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL5688674 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL20169071 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 | |
| SCHEMBL8335055 | 0.90 | TACR2 (0.42) | LGALS3TACR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007109561-A1 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | UNIVERSITY OF ALBERTA (CA) | 2007-09-27 | — | — | WO | disclosed |
| US-20070219144-A1 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | UNIVERSITY OF ALBERTA | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219144-A1 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | MTX1, MTX2, CSGALNACT1 | LGALS3 76/4885TACR2 4597/4885CA12 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.